Ali H. Ibrahim

693 total citations
6 papers, 442 citations indexed

About

Ali H. Ibrahim is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ali H. Ibrahim has authored 6 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Ali H. Ibrahim's work include Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers) and Chromatin Remodeling and Cancer (2 papers). Ali H. Ibrahim is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers) and Chromatin Remodeling and Cancer (2 papers). Ali H. Ibrahim collaborates with scholars based in United States, South Africa and Switzerland. Ali H. Ibrahim's co-authors include David MacPherson, Nan Wu, Emily Eastwood, Arnaud Augert, Deshui Jia, Ryan Basom, Eli Grunblatt, Keith D. Eaton, Renato Martins and Adi F. Gazdar and has published in prestigious journals such as Genes & Development, Cancer Cell and Science Advances.

In The Last Decade

Ali H. Ibrahim

6 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ali H. Ibrahim United States	5	284	282	163	77	68	6	442
Jan-Paul Lambooij Netherlands	5	216 0.8×	168 0.6×	60 0.4×	82 1.1×	65 1.0×	9	323
Eli Grunblatt United States	5	161 0.6×	149 0.5×	82 0.5×	46 0.6×	42 0.6×	11	268
Atsuko Umezawa Japan	8	97 0.3×	181 0.6×	126 0.8×	46 0.6×	106 1.6×	12	320
Heping Kan China	12	290 1.0×	89 0.3×	48 0.3×	221 2.9×	72 1.1×	18	425
Judit Matito Spain	9	218 0.8×	208 0.7×	23 0.1×	72 0.9×	97 1.4×	23	365
Hidenori Kitai Japan	8	232 0.8×	150 0.5×	24 0.1×	52 0.7×	89 1.3×	16	330
Abhilasha Sinha United States	12	188 0.7×	134 0.5×	35 0.2×	55 0.7×	46 0.7×	17	300
Xiaochuan Dong China	10	208 0.7×	139 0.5×	42 0.3×	93 1.2×	58 0.9×	16	422
Te-Sheng Chang Taiwan	6	146 0.5×	82 0.3×	95 0.6×	107 1.4×	24 0.4×	7	353
F. R. Hirsch United States	9	220 0.8×	247 0.9×	31 0.2×	71 0.9×	222 3.3×	26	449

Countries citing papers authored by Ali H. Ibrahim

Since Specialization

Citations

This map shows the geographic impact of Ali H. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali H. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali H. Ibrahim more than expected).

Fields of papers citing papers by Ali H. Ibrahim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali H. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali H. Ibrahim. The network helps show where Ali H. Ibrahim may publish in the future.

Co-authorship network of co-authors of Ali H. Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Ali H. Ibrahim. A scholar is included among the top collaborators of Ali H. Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali H. Ibrahim. Ali H. Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Freie, Brian, Ali H. Ibrahim, Patrick A. Carroll, et al.. (2025). MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues. Science Advances. 11(17). eadt3177–eadt3177. 3 indexed citations

2.

Augert, Arnaud, Haritha Mathsyaraja, Ali H. Ibrahim, et al.. (2020). MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer. Cancer Cell. 38(1). 97–114.e7. 51 indexed citations

3.

Grunblatt, Eli, Nan Wu, Huajia Zhang, et al.. (2020). MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity. Genes & Development. 34(17-18). 1210–1226. 68 indexed citations

4.

Augert, Arnaud, Emily Eastwood, Ali H. Ibrahim, et al.. (2019). Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition. Science Signaling. 12(567). 154 indexed citations

5.

Jia, Deshui, Arnaud Augert, Dong Wook Kim, et al.. (2018). Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discovery. 8(11). 1422–1437. 115 indexed citations

6.

Wu, Nan, Deshui Jia, Ali H. Ibrahim, et al.. (2016). NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer. Oncotarget. 7(36). 57514–57524. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact